T 03101
Alternative Names: T 3101Latest Information Update: 07 May 1998
At a glance
- Originator Antigenics; M. D. Anderson Cancer Center
- Class Antineoplastics
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glioma
Most Recent Events
- 07 May 1998 Discontinued-Preclinical for Glioma in USA (Unknown route)
- 20 Feb 1995 Preclinical development for Glioma in USA (Unknown route)